Health ❯ Healthcare ❯ Chronic Diseases

Obesity

Weight Management Type 2 Diabetes Treatment Options Health Complications Economic Impact of Obesity Public Health Management Strategies Obesity Management Semaglutide Diabetes Obesity-related Cancer Health Risks Metabolic Disorders Heart Disease Global Health Challenges Cardiovascular Health Cardiovascular Risk Obesity Treatments Impact on Heart Failure Treatment Strategies Weight Loss Strategies Treatment Guidelines MariTide Weight Loss Medications Comorbidities Childhood Obesity Prevalence in the US Patient Care Diet and Nutrition Youth Health Weight Management Strategies Management Health Programs Weight Loss Treatments Nonalcoholic Fatty Liver Disease Obstructive Sleep Apnea

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

The company released topline, open-label results that await full review.

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial

ESC Data Tie Wegovy and Mounjaro to Lower HFpEF Hospitalization and Death, With Novo Citing CV Edge for Wegovy

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes